Telangana

Dr. Reddy’s Institute of Life Sciences (DRILS) is a not for profit Research Institute with a mission to be the preferred research partner to the pharma and life sciences industry. DRILS focuses on original research and advancement of relevant skills, with emphasis on solution-oriented interdisciplinary research both for solving unmet needs as well as process innovation.

Post : Junior Research Scientist / Senior Research Scientist

MSN Group is one of the fastest growing manufacturers of Active Pharmaceutical Ingredients (APIs) and Finished dosages in India. Established in the year 2003, MSN Group comprises of 330 API manufacturing plants (including one for Oncology), three finished dosage facility ( including one for Oncology)and a dedicated R&D Center . Our plants are ISO 9001-2000 certified, WHO: GMP, EU:GMP and USFDA approved. Our manufacturing units are designed to confirm to the principles of Quality, Safety and sound Environment.

PAREXEL has supported the Bio-Tech and Pharmaceutical industries in helping the development of new drugs and treatments on a global basis. As a leading global biopharmaceutical service provider, they supply knowledge-based contract research, medical communications and consulting services across a broad range of therapeutic areas to the worldwide pharmaceutical, biotechnology and medical device industries.

Post : Project Manager

IIT Hyderabad is one among the 2nd generation of IITs started by the Govt. of India. Today IITH offers 9 B.Tech programs, 16 M.Tech programs, 3 M.Sc programs, 5 M.Phil programs, 1 M.Des program and Ph.D. programs in all branches of engineering, science, liberal arts and design. The very foundation of IIT Hyderabad is based on research and innovation. The vibrant research culture is evident from the number of patents and publications that IITH has.

IIT Hyderabad is one among the 2nd generation of IITs started by the Govt. of India. Today IITH offers 9 B.Tech programs, 16 M.Tech programs, 3 M.Sc programs, 5 M.Phil programs, 1 M.Des program and Ph.D. programs in all branches of engineering, science, liberal arts and design. The very foundation of IIT Hyderabad is based on research and innovation. The vibrant research culture is evident from the number of patents and publications that IITH has. At IITH students are given with a plethora of choices, which they diligently choose with the help of a faculty advisor. Courses that last for a semester are almost a foregone story at IITH.

Post : JRF/SRF-BIO

IIT Hyderabad is one among the 2nd generation of IITs started by the Govt. of India. Today IITH offers 9 B.Tech programs, 16 M.Tech programs, 3 M.Sc programs, 5 M.Phil programs, 1 M.Des program and Ph.D. programs in all branches of engineering, science, liberal arts and design. The very foundation of IIT Hyderabad is based on research and innovation. The vibrant research culture is evident from the number of patents and publications that IITH has. At IITH students are given with a plethora of choices, which they diligently choose with the help of a faculty advisor. Courses that last for a semester are almost a foregone story at IITH. From 14-15 academic year onwards all B.Tech programs started offering courses that are of smaller credits; called the fractal academics; very carefully designed to keep the enthusiasm of the students and to keep them in pace with the state of the art from 1st semester till 8th semester.

Post : Postdoctoral

Biophore, an established pharmaceutical company, is engaged in the development and manufacturing of niche pharmaceutical products for the generic industry. Within a decade since inception in 2007, Biophore has emerged as a trusted partner in the generic industry across US, Europe and other regulated markets.

Dr. Reddy’s commenced its generics business in India in 1986 and is today a trusted name in the healthcare industry consistently serving the needs of millions of patients with high quality, affordable and innovative medicines across therapy areas.

Post : Analyst – IPM (Formulations)

MSN Group is one of the fastest growing manufacturers of Active Pharmaceutical Ingredients (APIs) and Finished dosages in India. Established in the year 2003, MSN Group comprises of 330 API manufacturing plants (including one for Oncology), three finished dosage facility ( including one for Oncology)and a dedicated R&D Center . Our plants are ISO 9001-2000 certified, WHO: GMP, EU:GMP and USFDA approved. Our manufacturing units are designed to confirm to the principles of Quality, Safety and sound Environment.